Back to Trades
Lin Patrick
InsiderCIK 0001799363
Profile
- Filings
- 10
- Buy transactions
- 6
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Lin Patrick has filed 10 SEC reports (2025–2026), all concentrated in Processa Pharmaceuticals, Inc. (PCSA), totaling $64.8K in disclosed volume. Weighing $24.4K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $4.1K in Processa Pharmaceuticals, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jul 28 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Award | $0 |
| Jul 1 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Buy | $4.1K |
| Jun 16 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Buy | $4.1K |
| Jun 1 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Buy | $4.1K |
| May 19 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Buy | $4.1K |
| Apr 17 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Buy | $4.1K |
| Apr 1 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Buy | $4.1K |
| Feb 4 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Exercise | $0 |
| Oct 3 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Award | $40.4K |
| Jul 28 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick | Insider | Award | $0 |
10 filings